BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Lymphoma AND MLLT10, P55197, 8028, ENSG00000078403, AF10
77 results:

  • 1. Genetic Characterization of Pediatric Mixed Phenotype Acute Leukemia (MPAL).
    Panagopoulos I; Andersen K; Johannsdottir IMR; Tandsæther MR; Micci F; Heim S
    Cancer Genomics Proteomics; 2024; 21(1):1-11. PubMed ID: 38151288
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Challenging our understanding of B-cell lymphomagenesis and risk: Paediatric high-grade B-cell lymphoma, not otherwise specified with a DDX3X::mllt10 fusion and an IGH deletion.
    Hare L; Trotman J; Tarpey P; Hook E; Burke GAA;
    Pediatr Blood Cancer; 2024 Mar; 71(3):e30810. PubMed ID: 38102963
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Treatment outcomes of childhood PICALM::mllt10 acute leukaemias.
    Mark C; Meshinchi S; Joyce B; Gibson B; Harrison C; Bergmann AK; Goemans BF; Pronk CJH; Lapillonne H; Leverger G; Antoniou E; Schneider M; Attarbaschi A; Dworzak M; Stary J; Tomizawa D; Ebert S; Lejman M; Kolb EA; Schmiegelow K; Hasle H; Abla O
    Br J Haematol; 2024 Feb; 204(2):576-584. PubMed ID: 37743097
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Etiology of oncogenic fusions in 5,190 childhood cancers and its clinical and therapeutic implication.
    Liu Y; Klein J; Bajpai R; Dong L; Tran Q; Kolekar P; Smith JL; Ries RE; Huang BJ; Wang YC; Alonzo TA; Tian L; Mulder HL; Shaw TI; Ma J; Walsh MP; Song G; Westover T; Autry RJ; Gout AM; Wheeler DA; Wan S; Wu G; Yang JJ; Evans WE; Loh M; Easton J; Zhang J; Klco JM; Meshinchi S; Brown PA; Pruett-Miller SM; Ma X
    Nat Commun; 2023 Apr; 14(1):1739. PubMed ID: 37019972
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Diverse mutations and structural variations contribute to Notch signaling deregulation in paediatric T-cell lymphoblastic lymphoma.
    Salmerón-Villalobos J; Ramis-Zaldivar JE; Balagué O; Verdú-Amorós J; Celis V; Sábado C; Garrido M; Mato S; Uriz J; Ortega MJ; Gutierrez-Camino A; Sinnett D; Illarregi U; Carron M; Regueiro A; Galera A; Gonzalez-Farré B; Campo E; Garcia N; Colomer D; Astigarraga I; Andrés M; Llavador M; Martin-Guerrero I; Salaverria I
    Pediatr Blood Cancer; 2022 Nov; 69(11):e29926. PubMed ID: 36000950
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Clinico-biological features of T-cell acute lymphoblastic leukemia with fusion proteins.
    Steimlé T; Dourthe ME; Alcantara M; Touzart A; Simonin M; Mondesir J; Lhermitte L; Bond J; Graux C; Grardel N; Cayuela JM; Arnoux I; Gandemer V; Balsat M; Vey N; Macintyre E; Ifrah N; Dombret H; Petit A; Baruchel A; Ruminy P; Boissel N; Asnafi V
    Blood Cancer J; 2022 Jan; 12(1):14. PubMed ID: 35082269
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Is Radiation Therapy Cost-Effective in the Positron Emission Tomography/Computed Tomography Era for Early-Stage Favorable Hodgkin lymphoma With Alternative Payment Models?
    Kim H; Richman A; Smith KJ; Shaikh PM; Beriwal S; Vargo JA
    Pract Radiat Oncol; 2022; 12(2):e135-e143. PubMed ID: 34902637
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Fusion partner-specific mutation profiles and KRAS mutations as adverse prognostic factors in MLL-rearranged AML.
    Matsuo H; Yoshida K; Nakatani K; Harata Y; Higashitani M; Ito Y; Kamikubo Y; Shiozawa Y; Shiraishi Y; Chiba K; Tanaka H; Okada A; Nannya Y; Takeda J; Ueno H; Kiyokawa N; Tomizawa D; Taga T; Tawa A; Miyano S; Meggendorfer M; Haferlach C; Ogawa S; Adachi S
    Blood Adv; 2020 Oct; 4(19):4623-4631. PubMed ID: 32991719
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Failure of tofacitinib to achieve an objective response in a
    Wong J; Wall M; Corboy GP; Taubenheim N; Gregory GP; Opat S; Shortt J
    Cold Spring Harb Mol Case Stud; 2020 Aug; 6(4):. PubMed ID: 32843425
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Molecular and phenotypic characterization of an early T-cell precursor acute lymphoblastic lymphoma harboring PICALM-mllt10 fusion with aberrant expression of B-cell antigens.
    Khurana S; Melody ME; Ketterling RP; Peterson JF; Luoma IM; Vazmatzis G; Tun HW; Foran JM; Jiang L
    Cancer Genet; 2020 Jan; 240():40-44. PubMed ID: 31739126
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Transcriptome analysis offers a comprehensive illustration of the genetic background of pediatric acute myeloid leukemia.
    Shiba N; Yoshida K; Hara Y; Yamato G; Shiraishi Y; Matsuo H; Okuno Y; Chiba K; Tanaka H; Kaburagi T; Takeuchi M; Ohki K; Sanada M; Okubo J; Tomizawa D; Taki T; Shimada A; Sotomatsu M; Horibe K; Taga T; Adachi S; Tawa A; Miyano S; Ogawa S; Hayashi Y
    Blood Adv; 2019 Oct; 3(20):3157-3169. PubMed ID: 31648321
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Detection of novel fusion-transcripts by RNA-Seq in T-cell lymphoblastic lymphoma.
    López-Nieva P; Fernández-Navarro P; Graña-Castro O; Andrés-León E; Santos J; Villa-Morales M; Cobos-Fernández MÁ; González-Sánchez L; Malumbres M; Salazar-Roa M; Fernández-Piqueras J
    Sci Rep; 2019 Mar; 9(1):5179. PubMed ID: 30914738
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Acute leukemias harboring KMT2A/mllt10 fusion: a 10-year experience from a single genomics laboratory.
    Peterson JF; Sukov WR; Pitel BA; Smoley SA; Pearce KE; Meyer RG; Williamson CM; Smadbeck JB; Vasmatzis G; Hoppman NL; Greipp PT; Baughn LB; Ketterling RP
    Genes Chromosomes Cancer; 2019 Aug; 58(8):567-577. PubMed ID: 30707474
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Panoramic view of common fusion genes in a large cohort of Chinese de novo acute myeloid leukemia patients.
    Chen X; Wang F; Zhang Y; Wang M; Tian W; Teng W; Ma X; Guo L; Fang J; Zhang Y; Zhu P; Liu H
    Leuk Lymphoma; 2019 Apr; 60(4):1071-1078. PubMed ID: 30277115
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Mediastinal Myeloid Sarcoma with TP53 Mutation Preceding Acute Myeloid Leukemia with a PICALM-mllt10 Fusion Gene.
    Naesens L; Devos H; Nollet F; Michaux L; Selleslag D
    Acta Haematol; 2018; 140(2):97-104. PubMed ID: 30227397
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. KMT2A (MLL) rearrangements observed in pediatric/young adult T-lymphoblastic leukemia/lymphoma: A 10-year review from a single cytogenetic laboratory.
    Peterson JF; Baughn LB; Pearce KE; Williamson CM; Benevides Demasi JC; Olson RM; Goble TA; Meyer RG; Greipp PT; Ketterling RP
    Genes Chromosomes Cancer; 2018 Nov; 57(11):541-546. PubMed ID: 30203571
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Successful Treatment of a Very Late Isolated Relapse in an Adolescent With a PICALM-mllt10 Positive T-lineage Acute Lymphoblastic Leukemia.
    Cannata E; Samperi P; Cimino C; Marino S; Sullo F; Mirabile E; Di Cataldo A; Russo G; Lo Nigro L
    J Pediatr Hematol Oncol; 2018 Apr; 40(3):e191-e194. PubMed ID: 29189509
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. [Biological microchip for establishing the structure of fusion transcripts involving MLL in children with acute leukemia].
    Nasedkina TV; Ikonnikova AY; Tsaur GA; Karateeva AV; Ammour YI; Avdonina MA; Karachunskii AI; Zasedatelev AS
    Mol Biol (Mosk); 2016; 50(6):968-977. PubMed ID: 28064313
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. CATS (FAM64A) abnormal expression reduces clonogenicity of hematopoietic cells.
    Barbutti I; Xavier-Ferrucio JM; Machado-Neto JA; Ricon L; Traina F; Bohlander SK; Saad ST; Archangelo LF
    Oncotarget; 2016 Oct; 7(42):68385-68396. PubMed ID: 27588395
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. CCI-007, a novel small molecule with cytotoxic activity against infant leukemia with MLL rearrangements.
    Somers K; Chudakova DA; Middlemiss SM; Wen VW; Clifton M; Kwek A; Liu B; Mayoh C; Bongers A; Karsa M; Pan S; Cruikshank S; Scandlyn M; Hoang W; Imamura T; Kees UR; Gudkov AV; Chernova OB; Haber M; Norris MD; Henderson MJ
    Oncotarget; 2016 Jul; 7(29):46067-46087. PubMed ID: 27317766
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 4.